Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer SurvivorsMatthew R Trendowski, Heather E Wheeler, Omar El-Charif, et al.
American Journal of Human Genetics|April 29, 2008
Genetic architecture of transcript-level variation in humansShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.
Genes & Development|April 3, 2009
Mouse models of human AML accurately predict chemotherapy responseJohannes Zuber, Ina Radtke, Timothy S Pardee, et al.
The Lancet. Child & Adolescent Health|September 22, 2018
Peripheral neuropathy in children and adolescents treated for cancerKari L Bjornard, Laura S Gilchrist, Hiroto Inaba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral NeuropathyMasaaki Komatsu, Heather E Wheeler, Suyoun Chung, et al.
Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.
Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.
Genome Biology|November 30, 2019
RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variantsHai Lin, Katherine A Hargreaves, Rudong Li, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer SurvivorsMatthew R Trendowski, Heather E Wheeler, Omar El-Charif, et al.
American Journal of Human Genetics|April 29, 2008
Genetic architecture of transcript-level variation in humansShiwei Duan, R Stephanie Huang, Wei Zhang, et al.
Molecular Cancer Therapeutics|September 16, 2004
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutationsManny D Bacolod, Stewart P Johnson, Anthony E Pegg, et al.
Genes & Development|April 3, 2009
Mouse models of human AML accurately predict chemotherapy responseJohannes Zuber, Ina Radtke, Timothy S Pardee, et al.
The Lancet. Child & Adolescent Health|September 22, 2018
Peripheral neuropathy in children and adolescents treated for cancerKari L Bjornard, Laura S Gilchrist, Hiroto Inaba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2015
Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral NeuropathyMasaaki Komatsu, Heather E Wheeler, Suyoun Chung, et al.
Cancer Medicine|September 6, 2025
Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer SurvivorsSwetha Nakshatri, Paul C Dinh, Lawrence H Einhorn, et al.
Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.
Genome Biology|November 30, 2019
RegSNPs-intron: a computational framework for predicting pathogenic impact of intronic single nucleotide variantsHai Lin, Katherine A Hargreaves, Rudong Li, et al.
Pageof 19